AEON Biopharma宣布通过私募募集总额高达约2200万美元,并提议交换大雄可转换债券。
AEON Biopharma宣布通过私募募集总额高达约2200万美元,并提议交换大雄可转换债券。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.